Next Article in Journal
Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio B
Previous Article in Journal
Modulation of S100β and Inflammatory Signalling by Isorhamnetin Enhances Peripheral Nerve Regeneration
Previous Article in Special Issue
Ozonized Sunflower Oil: Standardization and Mechanisms of the Antimicrobial Effect
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review

by
Karyne Rangel
1,2,*,
Maria Helena Simões Villas-Bôas
3 and
Salvatore Giovanni De-Simone
1,2,4,*
1
Center for Technological Development in Health (CDTS), National Institute of Science and Technology for Innovation in Neglected Population Diseases (INCT-IDPN), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, RJ, Brazil
2
Laboratory of Epidemiology and Molecular Systematics (LESM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, RJ, Brazil
3
Microbiology Department, National Institute for Quality Control in Health (INCQS), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, RJ, Brazil
4
Post-Graduation Program in Science and Biotechnology, Department of Molecular and Cellular Biology, Biology Institute, Federal Fluminense University (U.F.F.), Niteroi 22040-036, RJ, Brazil
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2026, 27(8), 3632; https://doi.org/10.3390/ijms27083632
Submission received: 28 August 2025 / Revised: 11 September 2025 / Accepted: 17 September 2025 / Published: 18 April 2026
(This article belongs to the Special Issue Molecular Mechanisms of Ozone Therapy)

Abstract

The onset of the COVID-19 pandemic prompted the rapid development and deployment of novel strategies and methodologies to manage the dissemination of microorganisms. Understanding the crucial role that contaminated surfaces play in the spread of viruses highlights the importance of having effective cleaning and disinfection protocols in place for inanimate objects. A variety of antimicrobial agents have shown strong effectiveness against the SARS-CoV-2 virus. Various factors can impact on the performance of these agents. As a result, technologies utilizing ozone’s microbicidal effects have been developed or improved for cleaning indoor areas, surfaces, and materials, despite ozone’s diverse uses being known for years. Ozone offers the advantage of adaptability for both gaseous and aqueous use, depending on the nature of the decontaminated surfaces. Moreover, ozone-infused water is ecologically benign, possesses microbial-fighting capabilities, and synergistically reinforces the biocidal action of other chemical disinfectants. This review aims to summarize the efforts dedicated to harnessing gaseous and aqueous ozone as a valuable means to eliminate the SARS-CoV-2 virus from environments, surfaces, clinical equipment, and office supplies. This review sourced evidence-based articles from electronic databases, including MEDLINE (via PubMed), EMBASE, the Cochrane Library (CENTRAL), and preprint repositories. The findings illustrated that ozone could serve as an additional tool for curbing the proliferation of COVID-19 and other viral infections. Additionally, we elucidated the operational attributes of ozone, the variables that influence its disinfection potency, and the mechanisms of its virucidal action. Notably, this review does not encompass the disinfection of the COVID-19 virus in wastewater.

Graphical Abstract

1. Introduction

The ongoing global health crisis caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the resulting COVID-19 pandemic has profoundly impacted societies and economies worldwide, leading to millions of deaths [1]. While quantitative risk-assessment studies conclude that the probability of infection from contaminated surfaces, such as fomite transmission, is relatively minimal compared to direct person-to-person airborne transmission, concerns about microbial contamination have risen significantly during this pandemic. This heightened concern stems from the operational significance of surface transmission; even a low-probability risk becomes a significant public health concern when dealing with a highly infectious virus on a global scale. Since the onset of the pandemic, the emergence of new variants has continuously posed challenges for prevention and control efforts. Alongside the primary route of direct transmission, the potential risk of indirect transmission through contaminated surfaces and objects warrants attention [2,3,4,5]. These surfaces may indeed contribute to the spread of the virus, particularly in healthcare settings or high-touch public areas, justifying its consideration in mitigation strategies. It is important to note that this review focuses on the disinfection of air, surfaces, and fomites; the specific application of ozone for wastewater disinfection is beyond its scope [6,7,8].
Beyond direct person-to-person contact, research indicates that SARS-CoV-2 can spread through liquid droplets (short-range) and aerosols (long-range) when an infected individual talks, sings, breathes heavily, coughs, or sneezes [9]. Aerosol particles containing the virus can remain suspended indoors in closed or poorly ventilated spaces for at least 3 h [8]. Meanwhile, larger droplets, known as flügge droplets, do not disperse beyond 1.5 to 2 m from the source and remain airborne for a limited duration [7]. These emitted particles can settle on environmental surfaces and remain viable for hours to days, potentially leading to indirect transmission when individuals touch these surfaces and subsequently come into contact with their eyes, nose, or mouth [5,8]. SARS-CoV-2 can persist on hospital and household surfaces for up to 7 days [7]. Experimental studies have also demonstrated the virus’s ability to survive on various materials such as plastic, latex, glass, and metal for hours to days [10].
The advent of the COVID-19 pandemic underscored the importance of environmental-microbiological prevention and monitoring systems in responding to health crises and other threats [11,12,13]. While the initial vaccines have proven effective in reducing hospitalizations, infections, and deaths associated with COVID-19 [14,15,16], the constant emergence of new viral variants poses ongoing challenges [17,18]. Therefore, developing methods to ensure the disinfection of air, surfaces, fomites, and medical equipment has become paramount in interrupting the transmission chain. Implementing effective disinfection strategies remains crucial to controlling local transmissions through human-to-human contact, contaminated surfaces, or airborne particles. New disinfection approaches have the potential to significantly decrease case numbers during the current pandemic and future outbreaks.
The demand for virucidal disinfectants has surged since the outbreak of COVID-19, with more than five hundred disinfectants approved by the Environmental Protection Agency proving effective against SARS-CoV-2. However, their widespread use has raised concerns due to negative impacts on ecosystems and human health [19]. In this context, ozone disinfection is a viable option, having demonstrated high efficacy in eliminating bacteria, fungi, molds, and viruses, including the SARS virus [20,21,22,23]. It is important to note that prolonged exposure to high ozone concentrations can harm the human respiratory tract and damage construction materials, impacting air quality [24,25]. In Italy, the Ministry of Health has recognized ozone as a natural aid for sanitizing contaminated environments, further reinforcing its social legitimacy through the protocol issued on 31 July 1996 (24,482) [26].
It is essential to differentiate between the effects of gaseous ozone used for environmental disinfection and its activity within the human body [27,28]. While the primary aim of this review is to discuss environmental disinfection, it is pertinent to acknowledge that the pandemic has also shed light on the possible advantages of ozone therapy for treating COVID-19 patients. This approach has shown encouraging results, including helping to protect the heart and kidneys, improving oxygen flow in the body, boosting the immune system, reducing the risk of blood clots, and slowing down the virus’s ability to spread [29,30]. Recent studies suggest that ozone could be an alternative or adjuvant medical treatment for COVID-19 patients when used in conjunction with standard anti-inflammatory medications [31,32,33,34]. Ozone therapy involves creating a standardized mixture of oxygen and ozone (O2/O3), known as medicinal ozone [35]. The effects of ozone are primarily mediated through antioxidant systems, resulting in significant anti-inflammatory, immunomodulatory, and antiviral properties, as well as direct effects on coagulation and enhancements in microcirculation [36,37]. In the medical field, ozonated water is utilized for disinfecting surfaces and equipment, providing substantial advantages in dentistry through its efficacy in inactivating viruses, including coronaviruses [38,39,40,41,42]. The action of ozone is primarily dependent on direct contact with pathogens, with a radical mechanism becoming increasingly pronounced at pH levels exceeding 7 [43].
This mechanism holds particular importance for the localized treatment of infected wounds, as it facilitates the effective elimination of microorganisms and promotes wound cleansing, both of which are essential for the healing process [44]. In light of these considerations, the current review aims to elucidate the efficacy of ozone gas in inactivating or diminishing SARS-CoV-2 viruses on various surfaces, fomites, and in the air, while also assessing its potential to mitigate cross-contamination. Furthermore, the review will discuss the operational characteristics of ozone, the factors that influence its disinfection capabilities, and the mechanisms that underlie its virucidal actions.

2. Ozone Characteristics

Ozone (O3), a naturally occurring arrangement of three oxygen atoms (a triatomic gas and an oxygen allotrope), is a potent and environmentally friendly oxidizing agent known for its distinct pungent odor. It has a half-life of approximately one hour at room temperature and breaks down spontaneously to produce oxygen [45]. While ozone gas is bluish at room temperature, its presence is often not visually apparent. At a chilling −112 °C, condensed ozone transforms into a potentially explosive, dark-blue liquid [46]. Notably, ozone is significantly less stable than atmospheric oxygen [28], which means it does not accumulate and must be generated on demand through ozone generation systems [47,48]. Various techniques are used for ozone production, including Arc Discharge, dielectric barrier discharge, ultraviolet lamps, and electrostatic discharge/filter methods [49,50,51,52,53,54].
Ozone swiftly decomposes into oxygen in both water and air. It boasts a higher oxidative potential (2.07 V) than other oxidants such as potassium permanganate and chlorine. This high oxidative potential enables ozone to effectively oxidize a wide range of organic and inorganic compounds [55]. Although ozone is only slightly soluble in water, it has a much higher solubility compared to oxygen. At standard pressure and temperature, pure ozone dissolves at a remarkable rate of 641 mg/L, which is roughly 13 times more than oxygen [56]. In aquatic environments, ozone can produce reactive oxygen radicals through indirect oxidation processes [57]. This unique oxidative strength and rapid degradation make ozone a highly effective microbicidal agent, successfully targeting a broad spectrum of microorganisms, including bacteria, viruses, fungi, and protozoa [23,57,58,59,60].
As a result, ozone has a wide range of applications for disinfecting indoor spaces, surfaces, materials, food, and water. It can be used either in its gaseous form or dissolved in a solution, depending on the surface being targeted. Whether in aqueous or gaseous state, ozone is effective in decontaminating various surfaces. Hospital rooms can be disinfected using ozone gas, while dissolved ozone is used in the treatment of food and water [61]. Ozone’s microbicidal kinetics are faster than those of other oxidative agents used in chemical disinfectants, making it a safer alternative to chlorine, which generates harmful disinfection by-products and reacts significantly faster with organic matter [62]. Ozone has diverse applications across various industries due to its deodorizing, bleaching, and decontaminating properties.

3. Factors Influencing Ozone Disinfection

Ozone is a powerful substance that can kill many different germs and harmful microorganisms. However, the way it affects each type of germ can vary, depending on its unique biological makeup. The antimicrobial performance of ozone can be influenced by several parameters (as outlined in Table 1), including temperature, pressure, relative humidity, pH, conductivity, and the composition of organic matter [61]. In the context of surface disinfection, factors like ambient humidity, response time, material types, microorganism characteristics, ambient temperature, and surface properties all impact the efficacy of ozone disinfection [57]. The environmental factors of temperature, pressure, and relative humidity have a significant impact on gaseous ozonation. Additionally, factors such as pH, conductivity, and the composition of organic matter can significantly affect the effectiveness of aqueous ozone. Gaseous ozone is more effective at inactivating microorganisms when relative humidity is high [4,63].
Furthermore, the chemical composition, texture, and shape of the treated surface are crucial considerations for ozone disinfection. Material properties, whether absorbent or non-absorbent, the method of contamination (wet, dry, or droplets), the ozone generation technique, the type of microorganism, and the exposure dosage (ozone concentration over exposure duration) are key factors directly impacting the efficiency of the ozonation process [60]. In terms of water disinfection, parameters such as microorganism characteristics, water temperature, response time, organic matter, pH value, and turbidity all require evaluation [64,65]. In the case of aerosol disinfection, the principal factors include the concentration–time (CT) value (measured in mg/L/min), droplet size, and ambient humidity [50]. The CT value serves as a key indicator for assessing the effectiveness of ozone disinfection, as it reflects the combined effect of ozone concentration over time. A lower CT value indicates greater disinfection strength, requiring less time to reach a set sterilization rate [61].

4. Ozone Virucidal Mechanism

Viruses, being compact and simple in structure, lack cellular components and typically contain just one type of nucleic acid (DNA or RNA). These obligatory parasites rely on host cells for replication. The replication cycle of coronaviruses begins with the adsorption phase, during which the receptor-binding domain (RBD) of the S1 subunit of the spike glycoprotein interacts with specific receptors on the host cell membrane. This receptor specificity varies among different coronavirus species. For example, SARS-CoV-2 targets the human angiotensin-converting enzyme 2 (ACE2) receptor, facilitating the fusion of the viral envelope with the host cell membrane and subsequently releasing the viral RNA genome into the cytoplasm [66,67].
Ozone’s inactivation of viruses occurs through oxidative reactions with the fundamental biomolecules in these target organisms. This oxidation renders them incapable of initiating infections [68]. The virucidal potential of ozone also extends to aqueous environments [69,70]. Ozone’s impact encompasses damage to the viral envelope and genetic material. This process is accomplished through the direct oxidation of various molecules, peroxidation of phospholipids, and the generation of reactive oxygen species (ROS) [61]. Ozone and its ROS can oxidize various parts of enveloped or non-enveloped viruses, contributing to their inactivation (Figure 1). Like bacteria and fungi, ozone disrupts viruses through the peroxidation of lipids and proteins. This harms the viral lipid envelope and protein capsid, effectively neutralizing their ability to infect new cells [58]. A comprehensive review by Bayarri and colleagues highlights how ozone-mediated inactivation affects the molecular organization of viral genomes and the protein capsid [57]. The susceptibility of enveloped coronaviruses to ozone-induced damage might be greater due to the interaction between ozone and the lipid layers of their envelopes [71]. Ozone’s interaction with viral genomes involves molecular diffusion through external structures to reach the nucleic material. These external structures encompass the capsid and, in some cases, viral envelope proteins and lipids, as seen in the case of SARS-CoV-2 [72].
However, it is noteworthy that viruses are more resilient to ozone treatments than other microorganisms [73]. Molecular simulation studies have confirmed ozone’s ability to disrupt virus protein and lipid structures by targeting specific amino acids, such as cysteine, methionine, and tryptophan [51]. It is important to recognize that while knowledge of viral components contributes to understanding viral inactivation, it is not solely reliant on composition. Factors like viral structure and molecular organization play a role in determining the extent to which oxidants can access potential viral targets [74].

5. Inactivation of SARS-CoV-2 by Gaseous Ozone in Environments and on Surfaces

In response to the ongoing global COVID-19 pandemic, a comprehensive array of preventive and protective strategies has been implemented. Building on the success of ozone treatment against SARS-CoV-1 in 2002, researchers began investigating its effectiveness against SARS-CoV-2 due to the virus’ significant genetic similarity to SARS-CoV-1, at 80% [64]. As a result, ozone-based sanitation, in both gaseous and aqueous forms, has become a critical area of research, exploring its application in various environments, on surfaces, and on objects. This section focuses on studies examining ozone’s ability to neutralize the novel SARS-CoV-2 virus. It is essential to note that most of these studies utilized biologically safe viral surrogates that resemble SARS-CoV-2 in terms of form, function, and structure, as overseeing the live virus requires biosafety level 3 facilities [75,76].
Ozone gas has the potential to inactivate viruses present in contaminated spaces. A study found that ozone, high temperatures, and low humidity negatively affect coronavirus survival [77]. As ambient ozone concentration levels increased (from 48.83 to 94.67 μg/m3), together with relative humidity (23.33% to 82.67%) and temperature (−13.17 to 19 °C), a decrease in SARS-CoV-2 transmission was observed. Despite the low ozone concentration in the atmosphere lacking a direct inactivation effect, it displayed a relative inhibitory influence on the airborne transmission of SARS-CoV-2, thereby verifying the theoretical potential of utilizing active air disinfection to impede its spread [76]. De Forni et al. [78] used the ICON3 disinfection device to evaluate the effect of low ozone concentrations on inactivating SARS-CoV-2 isolates in an indoor environment devoid of individuals or animals. Findings indicated that exposure to low-concentration ozone (averaging 3.18 ppm) for 20 min could achieve over 99% inactivation of SARS-CoV-2. The study also subjected SARS-CoV-2 droplets (10, 3, and 0.5 μL) to varying ozone concentrations (ranging from 5.44 to 1.47 ppm) for 20 min, yielding significant inactivation results. A parallel assessment showed that ICON3’s ozone disinfection efficiency increases linearly with room volume in controlled rooms of 15, 30, and 60 m3. These findings suggested the potential utilization of ICON3 for SARS-CoV-2 disinfection in unoccupied indoor environments under controlled and secure conditions. A study evaluated the inactivating effects of hypochlorous acid, chlorine dioxide, and ozone on SARS-CoV-2 and influenza A virus in the air using a standardized assessment system. The results showed that viral infectivity titers decreased in a concentration- and time-dependent manner. Ozone at 1.0 ppm achieved an approximately 2 log reduction in SARS-CoV-2 infectivity within 10 min. However, SARS-CoV-2 remained detectable in the air under conditions where the influenza A virus was inactivated below detection limits. These findings highlight ozone’s effectiveness in reducing airborne SARS-CoV-2 and influenza A virus [79]. Albert et al. [27] quantified the efficacy, safety, and effectiveness of the aqueous ozone spray using a crewless aerial vehicle. Optimized flight parameters ensured coverage exceeding 97% on external surfaces. In spray operations employing 1 mg/L aqueous ozone, atmospheric ozone concentrations remained consistent with background levels (≤0.04 ppm). The study demonstrated the efficient inactivation of two SARS-CoV-2 strains in just 5 min under a 0.75 mg/L ozone concentration, while a 0.375 mg/L concentration achieved 82–91.5% inactivation. Results confirmed the capacity of aqueous ozone to effectively eliminate the virus while maintaining safety standards for both humans and the environment [27]. A recent investigation, which applied ozone treatment at varying concentrations to office supplies (e.g., personal computer monitors, keyboards, and computer mice) and clinical equipment (such as continuous positive airway pressure tubes and personal protective equipment), revealed that a 90 ppm ozone treatment for 120 min yielded optimal effectiveness for disinfecting larger volume supplies. Furthermore, a 4000 ppm ozone concentration achieved SARS-CoV-2 RNA elimination over smaller surfaces in 10 min or less, as assessed by RT-qPCR [80].
Surface disinfection plays a pivotal role in combating COVID-19. In response to the health emergency, studies evaluating the efficacy of ozone in deactivating viruses on surfaces or fomites have emerged. Personal protective equipment (PPE) serves as a crucial physical barrier, safeguarding medical personnel. In cases of resource scarcity, reusing PPE underscores the necessity of effective SARS-CoV-2 inactivation. Ozone treatment demonstrated remarkable efficacy in inactivating SARS-CoV-2-contaminated PPE. The capacity of ozone to neutralize SARS-CoV-2 on contaminated protective garments and masks was assessed across various exposure durations, concentrations, and humidity levels. Although the authors confirmed the presence of viral genetic material using RT-PCR, quantification of inactivation remained absent. At ozone concentrations ≥ 2000 ppm, disinfection of SARS-CoV-2 on the surface of contaminated PPE was achieved in under 10 min. Notably, a concentration of 10,000 ppm facilitated disinfection within 30 s. The effects at lower ozone concentrations (4–12 ppm) were heavily contingent upon relative humidity conditions. Nonetheless, the authors concluded that ozonation presented a viable avenue for PPE disinfection. Notably, CT values (where CT represents ozone concentration multiplied by exposure time) of 9.8 mg/L/min were found to render the viral genetic material undetectable (under ≤ 99% relative humidity conditions) [81]. A recent study demonstrated that gaseous ozone at 800 ppm could decontaminate cotton, FFP3 face masks, and glass slides contaminated with SARS-CoV-2 within 10 to 60 min, resulting in a reduction of over 6 logs. This study also highlighted the prevention of ozone-mediated virus inactivation due to surface tension when viral droplets were placed on glass surfaces [82]. DBD plasma (ozone concentration of 120 ppm at a power of 13 W) produced ozone gases capable of eliminating HCoV-229E from the surface of Korean face mask-94 (KF94) under varying exposure times ranging from 10 to 300 s. A 10 s exposure at 120 ppm ozone concentration reduced the viral RNA load by 4 log orders [83]. Another study investigated the inactivation of SARS-CoV-2 and its surrogate, Human Coronavirus OC43 (HCoV-OC43), on representative porous (KN95 mask material) and nonporous surfaces (aluminum and polycarbonate) using a Compact Portable Plasma Reactor (CPPR). Iterative experiments were conducted on inoculated material samples across three operating volumes, and the results showed that minimum CPPR exposure times of 5 to 15 min achieved a 4–5 log reduction in SARS-CoV-2 and its surrogate on the tested materials [84].
Research highlights ozone’s effectiveness in disinfecting surfaces, but it is also important to recognize how different surface materials affect the inactivation of viruses. Specifically, rigid and inert surfaces, such as stainless steel, glass, and plastic, demonstrated similar rates of virus inactivation when treated with ozone. Conversely, porous materials (e.g., floors) or copper surfaces showed the ability to inactivate the virus even in the absence of ozone. Remarkably, copper possesses antimicrobial properties and can deactivate SARS-CoV-2 in minutes [85]. The study by Yano et al. [86] was the pioneering endeavor to demonstrate a 3.3 log10 reduction in SARS-CoV-2 on stainless steel plates, achieved through exposure to 6 ppm ozone gas for 55 min at a relative humidity of 60–80%. Subsequently, another study demonstrated the effectiveness of ozonated water (0.2–0.8 ppm) against SARS-CoV-2, resulting in a 2 log10 reduction in virus infectivity after just 1 min of exposure [38]. A thorough investigation was conducted to assess the impact of ozone on the viability of SARS-CoV-2 across eight different surfaces, including stainless steel, both painted and unpainted aluminum, acrylic, glass, plastic, FFP2 masks, and surgical gowns. This study took place inside a sealed acrylic box to ensure controlled conditions. While temperature, relative humidity, and ozone emission remained constant, both ozone concentration (ranging from 0.5 to 2 ppm) and exposure time (40 and 60 min) [87] were varied.
To reduce the risk of fomite-mediated transmission of SARS-CoV-2, various surface disinfection and sanitization techniques have been proposed. A study assessing the efficacy and feasibility of gaseous ozone disinfection in a public bus setting used murine hepatitis virus (a surrogate for betacoronaviruses) and Staphylococcus aureus as test organisms. The findings indicated that an optimal gaseous ozone regimen achieved a 3.65 log reduction in murine hepatitis virus and a 4.73 log decrease in S. aureus. Additionally, decontamination efficacy was influenced by exposure duration and relative humidity within the application space [88]. Frizziero et al. introduced a new sanitization device specifically designed for helmets used in bike-sharing services. This innovative system uses ozone to effectively remove dust and bacteria from the helmet’s surface, addressing rising concerns about hygiene and safety in shared transportation [89].

6. Inactivation of SARS-CoV-2 by Ozonated Water and Influencing Factors

A substantial reduction in SARS-CoV-2 titer was observed across the three tested concentrations after a 40 min fumigation period on all surfaces. Notably, the disinfection efficiency did not exhibit a direct proportionality to the concentration used [81]. Westover et al. [90] further substantiated these findings, noting a significant degradation of synthetic SARS-CoV-2 RNA commonly encountered materials: glass, plastic, gauze, wood, fleece, and wool. Ozone exposure at 0.2 ppm over 2 h effectively disinfected wool samples by 99.99%, followed by diminishing efficacy for gauze (96.8%), wood (93.3%), glass (90%), and plastic (82.2%). Similarly, exposing these materials to 4 ppm ozone for 30 min achieved a 90% reduction in viral titers [28].
In addition to the previously discussed factors, the composition of the media plays a crucial role in inactivating viruses. Ozonated water has proven to be an effective alternative for environmental disinfection. Remarkably, just one minute of exposure can achieve a reduction of 2.0 to 5.0 log10 in SARS-CoV-2 titers [91]. Tizaoui et al. [92] demonstrated the ability of both aqueous and gaseous ozone to inactivate SARS-CoV-2. The virus was suspended in liquid and also dried on different surfaces, including glass, polystyrene (a type of plastic), copper, stainless steel, ambulance seats, and floor samples. The study revealed a significant difference in ozone flux between liquid and dry surfaces. This differential suggested that rehydrating a dry viral medium amplifies its exposure to ozone, ultimately leading to inactivation [92]. Ozonated water itself demonstrated robust virucidal activity against SARS-CoV-2 [92]. In a study by Hu et al. [93], a mere 1 min exposure to ozonated water (at concentrations of 36 mg/L and 18 mg/L) resulted in complete inactivation of environmental SARS-CoV-2 contamination, with no detection of viral genomic RNA or viral plaques. However, further investigations are warranted to assess the effectiveness of ozone-based water disinfection under real-world conditions [85].
Additionally, the study highlighted the enhancement of microbicidal disinfection efficiency with ozonated water, regardless of the type of disinfectant, which contributed to reduced disinfectant concentrations and mitigated microbial resistance [93]. A study evaluating the effectiveness of different disinfection methods—including conventional chemical methods, ozonated water, and ultraviolet irradiation—on three SARS-CoV-2 variants in hospital settings found that ozonated water at 7 ppm (with a virus-to-test solution ratio of 1:9) did not exhibit clinically significant antiviral activity. The reduction in viral activity was less than 1 log, which is below the virucidal efficacy seen with conventional chemical disinfectants [94]. However, a previous study emphasized that the ratio of virus to test solution is a crucial factor affecting the antiviral effectiveness of ozonated water [95]. To evaluate the impact of organic factors in saliva on the efficacy of ozonated water against SARS-CoV-2, researchers exposed ozonated water to salivary components and measured residual ozone concentrations. Ozonated water inactivated SARS-CoV-2 within 30 s, but its efficacy decreased as protein concentration increased. Higher ozone concentrations (1.5 mg/L) were more effective than lower concentrations (0.5 mg/L). This reduction occurred despite identical initial ozone concentrations and contact times, likely due to ozone degradation by the proteins [96]. Supplementary studies elucidating ozone’s virucidal activity against SARS-CoV-2 are briefly summarized in Table 2.

7. Conclusions

In response to the global imperative for enhanced decontamination methods, this comprehensive review underscores the considerable potential of ozone as an efficient and environmentally friendly solution against SARS-CoV-2. Gaseous ozone has proven to be an effective option for inactivating viruses on various surfaces and materials. However, achieving the best treatment results requires careful consideration of its concentration and volume. Similarly, aqueous ozone serves as a viable and sustainable alternative to traditional chemical disinfectants. Together, these findings highlight the potential of ozone as a valuable tool in reducing the transmission of COVID-19. Based on the available body of evidence, our recommendation involves the use of gaseous ozone at concentrations exceeding 4000 ppm, sustained for a minimum of 10 min, to achieve substantial inactivation of SARS-CoV-2 on surfaces and materials.
Aqueous ozone stands out as a highly effective and environmentally friendly disinfectant for liquid media, providing a strong safety profile. Ensuring precise ozone generation and exposure parameters is crucial to eliminating any potential health risks. While the reviewed studies present valuable insights, they also have limitations, including modest sample sizes and variations in experimental conditions. Therefore, continued research is vital to further confirm and enhance the efficacy of ozone in real-world applications against SARS-CoV-2.

Author Contributions

Conceptualization and Investigation: S.G.D.-S. and K.R.; Funding: S.G.D.-S.; Methodology: K.R. and M.H.S.V.-B.; Writing—original draft: K.R.; Review and editing: S.G.D.-S. All authors have read and agreed to the published version of the manuscript.

Funding

The Brazilian Council for Scientific Research (CNPq #30515-2020-5) and the Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ #200.960-2022) supported this research.

Acknowledgments

K.R. is supported by CAPES/CDTS-FIOCRUZ.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Mofijur, M.; Fattah, I.M.R.; Alam, M.A.; Islam, A.B.M.S.; Ong, H.C.; Rahman, S.M.A.; Najafi, G.; Ahmed, S.F.; Uddin, M.A.; Mahlia, T.M.I. Impact of COVID-19 on the social, economic, environmental, and energy domains: Lessons learned from a global pandemic. Sustain. Prod. Consum. 2021, 26, 343–359. [Google Scholar] [CrossRef]
  2. Caggiano, G.; Triggiano, F.; Apollonio, F.; Diella, G.; Lopuzzo, M.; D’Ambrosio, M.; Fasano, F.; Stefanizzi, P.; Sorrenti, G.T.; Magarelli, P.; et al. SARS-CoV-2 RNA and supermarket surfaces: A real or presumed threat? Int. J. Environ. Res. Public Health 2021, 18, 9404. [Google Scholar] [CrossRef]
  3. Petrillo, S.; Carrà, G.; Bottino, P.; Zanotto, E.; De Santis, M.C.; Margaria, J.P.; Giorgio, A.; Mandili, G.; Martini, M.; Cavallo, R.; et al. A novel multiplex qRT-PCR assay to detect SARS-CoV-2 infection: High sensitivity and increased testing capacity. Microorganisms 2020, 8, 1064. [Google Scholar] [CrossRef]
  4. Chia, P.Y.; Coleman, K.K.; Tan, Y.K.; Ong, S.W.X.; Gum, M.; Lau, S.K.; Lim, X.F.; Lim, A.S.; Sutjipto, S.; Lee, P.H.; et al. Singapore 2019 Novel Coronavirus Outbreak Research Team. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat. Commun. 2020, 11, 2800. [Google Scholar] [CrossRef] [PubMed]
  5. Mondelli, M.U.; Colaneri, M.; Seminari, E.M.; Baldanti, F.; Bruno, R. Low risk of SARS-CoV-2 transmission by fomites in real-life conditions. Lancet Infect. Dis. 2021, 21, e112. [Google Scholar] [CrossRef]
  6. Harvey, A.P.; Fuhrmeister, E.R.; Cantrell, M.E.; Pitol, A.K.; Swarthout, J.M.; Powers, J.E.; Nadimpalli, M.L.; Julian, T.R.; Pickering, A.J. Longitudinal monitoring of SARS-CoV-2 RNA on high-touch surfaces in a community setting. Environ. Sci. Technol. Lett. 2021, 8, 168–175. [Google Scholar] [CrossRef]
  7. Liu, Y.; Li, T.; Deng, Y.; Liu, S.; Zhang, D.; Li, H.; Wang, X.; Jia, L.; Han, J.; Bei, Z. Stability of SARS-CoV-2 on environmental surfaces and in human excreta. J. Hosp. Infect. 2021, 107, 105–107. [Google Scholar] [CrossRef]
  8. Van Doremalen, N.; Bushmaker, T.; Morris, D.H.; Holbrook, M.G.; Gamble, A.; Williamson, B.N.; Tamin, A.; Harcourt, J.L.; Thornburg, N.J.; Gerber, S.I. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 2020, 382, 1564–1567. [Google Scholar] [CrossRef] [PubMed]
  9. Jayaweera, M.; Perera, H.; Gunawardana, B.; Manatunge, J. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ. Res. 2020, 188, 109819. [Google Scholar] [CrossRef] [PubMed]
  10. Aboubakr, H.A.; Sharafeldin, T.A.; Goyal, S.M. Stability of SARS-CoV and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: A review. Transbound. Emerg. Dis. 2020, 68, 296–312. [Google Scholar] [CrossRef]
  11. Irie, M.S.; Dietrich, L.; Souza, G.L.; Soares, P.B.F.; Moura, C.C.G.; Silva, G.R.D.; Paranhos, L.R. Ozone disinfection for viruses with applications in healthcare environments: A scoping review. Braz. Oral. Res. 2022, 36, e006. [Google Scholar] [CrossRef] [PubMed]
  12. Gola, M.; Caggiano, G.; De Giglio, O.; Napoli, C.; Diella, G.; Carlucci, M.; Carpagnano, L.F.; D’Alessandro, D.; Joppolo, C.M.; Capolongo, S.; et al. SARS-CoV-2 indoor contamination: Considerations on anti-COVID-19 management of ventilation systems and finishing materials in healthcare facilities. Ann. Ig. 2021, 33, 381–392. [Google Scholar] [CrossRef]
  13. Rangel, K.; De-Simone, S.G. Acinetobacter baumannii during COVID-19: What is the real pandemic? Pathogens 2023, 12, 41. [Google Scholar] [CrossRef] [PubMed]
  14. Tregoning, J.S.; Wang, Z.; Sridhar, S.; Shattock, R.J.; DeRosa, F. Immunology of RNA-based vaccines: The critical interplay between inflammation and expression. Mol. Ther. 2025, 8, 1–56. [Google Scholar] [CrossRef]
  15. Moghadas, S.M.; Vilches, T.N.; Zhang, K.; Wells, C.R.; Shoukat, A.; Singer, B.H.; Meyers, L.A.; Neuzil, K.M.; Langley, J.M.; Fitzpatrick, M.C.; et al. The impact of vaccination on COVID-19 outbreaks in the United States. Clin. Infect. Dis. 2021, 73, 2257–2264. [Google Scholar] [CrossRef]
  16. Tenforde, M.W.; Olson, S.M.; Self, W.H.; Talbot, H.K.; Lindsell, C.J.; Steingrub, J.S.; Shapiro, N.I.; Ginde, A.A.; Douin, D.J.; Prekker, M.E.; et al. Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged ≥65 years—United States January-March 2021. MMWR Morb. Mortal. Wkly. Rep. 2021, 70, 674–679. [Google Scholar] [CrossRef]
  17. Leung, K.; Shum, M.H.; Leung, G.M.; Lam, T.T.; Wu, J.T. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom: October to November 2020. Euro Surveill. 2021, 26, 2002106, Erratum in: Euro Surveill. 2021, 26, 210121a. https://doi.org/10.2807/1560-7917.ES.2021.26.3.210121a. [Google Scholar] [CrossRef]
  18. Makoni, M. South Africa responds to new SARS-CoV-2 variant. Lancet 2021, 397, 267. [Google Scholar] [CrossRef]
  19. Dewey, H.M.; Jones, J.M.; Keating, M.R.; Budhathoki-Uprety, J. Increased use of disinfectants during the COVID-19 pandemic and its potential impacts on health and safety. ACS Chem. Health Saf. 2022, 29, 27–38. [Google Scholar] [CrossRef]
  20. Manjunath, S.N.; Sakar, M.; Katapadi, M.; Geetha Balakrishna, R. Recent case studies on the use of ozone to combat coronavirus: Problems and perspectives. Environ. Technol. Innov. 2021, 21, 101313. [Google Scholar] [CrossRef] [PubMed]
  21. Rangel, K.; Cabral, F.O.; Lechuga, G.C.; Carvalho, J.P.R.S.; Villas-Bôas, M.H.S.; Midlej, V.; De-Simone, S.G. Detrimental effect of ozone on pathogenic bacteria. Microorganisms 2022, 10, 40. [Google Scholar] [CrossRef] [PubMed]
  22. Rangel, K.; Cabral, F.O.; Lechuga, G.C.; Carvalho, J.P.R.S.; Villas-Bôas, M.H.S.; Midlej, V.; De-Simone, S.G. Potent activity of high concentrations of chemical ozone against antibiotic-resistant bacteria. Molecules 2022, 27, 3998. [Google Scholar] [CrossRef]
  23. Liu, J.; Yue, P.; Huang, L.; Zhao, M.; Kang, X.; Liu, X. Styrene removal with an acidic biofilter with four packing materials: Performance and fungal bioaerosol emissions. Environ. Res. 2020, 191, 110154. [Google Scholar] [CrossRef]
  24. Zanardi, I.; Borrelli, E.; Valacchi, G.; Travagli, V.; Bocci, V. Ozone: A multifaceted molecule with unexpected therapeutic activity. Curr. Med. Chem. 2015, 23, 304–314. [Google Scholar] [CrossRef]
  25. Shen, J.; Gao, Z. Ozone removal on building material surface: A literature review. Build. Environ. 2018, 134, 205–217. [Google Scholar] [CrossRef]
  26. Istituto Superiore di Sanità, Focus on the Professional Use of Ozone Also in Reference to COVID-19 Working Group ISS-INAIL. 2020. Available online: https://www.iss.it/en/pubblicazioni-focus/-/asset_publisher/GIDBUf2rmBr2/content/id/5524886 (accessed on 15 July 2025).
  27. Albert, S.; Amarilla, A.A.; Trollope, B.; Sng, J.D.J.; Setoh, Y.X.; Deering, N.; Modhiran, N.; Weng, S.H.; Melo, M.C.; Hutley, N.; et al. Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2. Environ. Res. 2021, 196, 110944. [Google Scholar] [CrossRef] [PubMed]
  28. Criscuolo, E.; Diotti, R.A.; Ferrarese, R.; Alippi, C.; Viscardi, G.; Signorelli, C.; Mancini, N.; Clementi, M.; Clementi, N. Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials. Emerg. Microbes Infect. 2021, 10, 206–210. [Google Scholar] [CrossRef]
  29. Martínez-Sánchez, G.; Schwartz, A.; Donna, V.D. Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19. Antioxidants 2020, 9, 389. [Google Scholar] [CrossRef]
  30. Yousefi, B.; Banihashemian, S.Z.; Feyzabadi, Z.K.; Hasanpour, S.; Kokhaei, P.; Abdolshahi, A.; Emadi, A.; Eslami, M. Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 disease. Med. Gas Res. 2022, 12, 33–40. [Google Scholar] [CrossRef]
  31. Shang, W.; Wang, Y.; Wang, G.; Han, D. Benefits of ozone on mortality in patients with COVID-19: A systematic review and meta-analysis. Complement. Ther. Med. 2023, 72, 102907. [Google Scholar] [CrossRef] [PubMed]
  32. Jafari-Oori, M.; Vahedian-Azimi, A.; Ghorbanzadeh, K.; Sepahvand, E.; Dehi, M.; Ebadi, A.; Izadi, M. Efficacy of ozone adjuvant therapy in COVID-19 patients: A meta-analysis study. Front. Med. 2022, 10, 1037749. [Google Scholar] [CrossRef]
  33. Budi, D.S.; Rofananda, I.F.; Pratama, N.R.; Sutanto, H.; Hariftyani, A.S.; Desita, S.R.; Rahmasari, A.Z.; Asmarawati, T.P.; Waskito, L.A.; Wungu, C.D.K. Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis. Int. Immunopharmacol. 2022, 110, 109014. [Google Scholar] [CrossRef]
  34. Cenci, A.; Macchia, I.; La Sorsa, V.; Sbarigia, C.; Di Donna, V.; Pietraforte, D. Mechanisms of action of ozone therapy in emerging viral diseases: Immunomodulatory effects and therapeutic advantages with reference to SARS-CoV-2. Front. Microbiol. 2022, 21, 871645. [Google Scholar] [CrossRef]
  35. Smith, N.L.; Wilson, A.L.; Gandhi, J.; Vatsia, S.; Khan, S.A. Ozone therapy: An overview of pharmacodynamics current research and clinical utility. Med. Gas. Res. 2017, 7, 212–219. [Google Scholar] [CrossRef] [PubMed]
  36. Bocci, V.; Valacchi, G.; Corradeschi, F.; Fanetti, G. Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and interleukin-8 production. Mediat. Inflamm. 1998, 7, 313–317. [Google Scholar] [CrossRef]
  37. Ranaldi, G.T.; Villani, E.R.; Franza, L. Rationale for ozone-therapy as adjuvant therapy in COVID-19: A narrative review. Med. Gas. Res. 2020, 10, 134–138. [Google Scholar] [CrossRef]
  38. Martins, R.B.; Castro, I.A.; Pontelli, M.; Souza, J.P. SARS-CoV-2 inactivation by ozonated water: A preliminary alternative for environmental disinfection. Ozone Sci. Eng. 2021, 43, 108–111. [Google Scholar] [CrossRef]
  39. Inagaki, H.; Akatsuki, S.; Sudaryatma, P.E.; Sugiyamaa, H.; Okabayash, Y.; Fujimoto, S. Rapid inactivation of SARS-CoV-2 with ozonated water. Ozone Sci. Eng. 2021, 43, 208–212. [Google Scholar] [CrossRef]
  40. El Meligy, O.A.; Elemam, N.M.; Talaat, I.M. Ozone therapy in medicine and dentistry: A review of the literature. Dent. J. 2023, 11, 187. [Google Scholar] [CrossRef] [PubMed]
  41. Hudson, J.B.; Sharma, M.; Vimalanathan, S. Development of a practical method for using ozone gas as a virus decontaminating agent. Ozone Sci. Eng. 2009, 31, 216–223. [Google Scholar] [CrossRef]
  42. Morrison, C.; Atkinson, A.; Zamyadi, A.; Kibuye, F.; McKie, M.; Hogard, S.; Mollica, P.; Jasim, S.; Wert, E.C. Critical review and research needs of ozone applications related to virus inactivation: Potential implications for SARS-CoV-2. Ozone Sci. Eng. 2021, 43, 2–20. [Google Scholar] [CrossRef]
  43. Hoigne, L.; Baderm, H. Ozonation of water: Selectivity and rate of oxidation of solutes. Ozone Sci. Eng. 1979, 1, 73–85. [Google Scholar] [CrossRef]
  44. Viebahn-Haensler, R.; León Fernández, O.S. Ozone in medicine. The low-dose ozone concept and its basic biochemical mechanisms of action in chronic inflammatory diseases. Int. J. Mol. Sci. 2021, 22, 7890. [Google Scholar] [CrossRef]
  45. Kumar, G.D.; Williams, R.C.; Sumnerm, S.S.; Eifertm, J.D. Effect of ozone and ultraviolet light on Listeria monocytogenes populations in fresh and spent chill brines. Food Cont. 2016, 59, 172–177. [Google Scholar] [CrossRef]
  46. Guzel-Seydim, Z.B.; Greene, A.K.; Seydim, A.C. Use of ozone in the food industry. LWT-Food Sci. Technol. 2004, 37, 453–460. [Google Scholar] [CrossRef]
  47. Joseph, C.G.; Farm, Y.Y.; Taufiq-Yap, Y.H.; Pang, C.K.; Nga, J.L.H.; Puma, G.L. Ozonation treatment processes for the remediation of detergent wastewater: A comprehensive review. J. Environ. Chem. Eng. 2021, 9, 106099. [Google Scholar] [CrossRef]
  48. Mousazadeh, M.; Kabdaşlı, I.; Khademi, S.; Sandoval, M.A.; Moussavi, S.P.; Malekdar, F.; Gilhotra, V.; Hashemi, M.; Dehghani, M.H. A critical review on the existing wastewater treatment methods in the COVID-19 era: What is the potential of advanced oxidation processes in combatting viral especially SARS-CoV-2? J. Water Process Eng. 2022, 49, 103077. [Google Scholar] [CrossRef] [PubMed]
  49. Pawrat, J.; Terebun, P.; Kwiatkowski, M.; Tarabová, B.; Kovaľová, Z.; Kučerová, K.; Machala, Z.; Janda, M.; Hensel, K. Evaluation of oxidative species in gaseous and liquid phase generated by mini-gliding arc discharge. Plasma Chem. Plasma Process 2019, 39, 627–642. [Google Scholar] [CrossRef]
  50. Dobslaw, D.; Schulz, A.; Helbich, S.; Dobslaw, C. VOC removal and odor abatement by a low-cost plasma enhanced bio trickling filter process. J. Environ. Chem. Eng. 2017, 5, 5501–5511. [Google Scholar] [CrossRef]
  51. Dobslaw, D.; Ortlinghaus, O.; Dobslaw, C. A combined process of non-thermal plasma and a low-cost mineral adsorber for V.O.C. removal and odor abatement in emissions of organic waste treatment plants. J. Environ. Chem. Eng. 2018, 6, 2281–2289. [Google Scholar] [CrossRef]
  52. Park, C.H.; Byeon, J.H.; Yoon, K.Y.; Park, J.; Hwang, J. Simultaneous removal of odors airborne particles and bioaerosols in a municipal composting facility by dielectric barrier discharge. Sep. Purif. Technol. 2011, 77, 187–193. [Google Scholar] [CrossRef]
  53. Claus, H. Ozone generation by ultraviolet lamps. Photochem. Photobiol. 2021, 97, 471–476. [Google Scholar] [CrossRef]
  54. Boelter, K.J.; Davidson, J.H. Ozone generation by indoor electrostatic air cleaners. Aerosol Sci. Technol. 2007, 27, 689–708. [Google Scholar] [CrossRef]
  55. Caniani, D.; Caivano, M.; Mazzone, G.; Mais, S.; Mancini, I.M. Effect of site-specific conditions and operating parameters on the removal efficiency of petroleum-originating pollutants using ozonation. Sci. Total Environ. 2021, 800, 149393. [Google Scholar] [CrossRef] [PubMed]
  56. Egorova, G.V.; Voblikova, V.A.; Sabitova, L.V.; Tkachenko, I.S. Ozone solubility in water. Mosc. Univ. Chem. Bull. 2015, 70, 207–210. [Google Scholar] [CrossRef]
  57. Bayarri, B.; Cruz-Alcalde, A.; Lopez-Vinent, N.; Micó, M.M.; Sans, C. Can ozone inactivate SARS-CoV-2? A review of mechanisms and performance on viruses. J. Hazard. Mater. 2021, 415, 125658. [Google Scholar] [CrossRef] [PubMed]
  58. Tizaoui, C. Ozone: A potential oxidant for COVID-19 Virus (SARS-CoV-2). Ozone Sci. Eng. 2020, 42, 378–385. [Google Scholar] [CrossRef]
  59. Skowron, K.; Wałecka-Zacharska, E.; Grudlewska, K.; Białucha, A.; Wiktorczyk, N.; Bartkowska, A.; Kowalska, M.; Kruszewski, S.; Gospodarek-Komkowska, E. Biocidal effectiveness of selected disinfectant solutions based on water and ozonated water against Listeria monocytogenes strains. Microorganisms 2019, 7, 127. [Google Scholar] [CrossRef]
  60. Erickson, M.C.; Ortega, Y.R. Inactivation of protozoan parasites in food, water, and environmental systems. J. Food Prot. 2006, 26, 2786–2808. [Google Scholar] [CrossRef]
  61. Epelle, E.I.; Macfarlane, A.; Cusack, M.; Burns, A.; Okolie, J.A.; Mackay, W.; Rateb, M.; Yaseen, M. Ozone application in different industries: A review of recent developments. Chem. Eng. J. 2023, 454, 140188. [Google Scholar] [CrossRef]
  62. Cai, Y.; Zhao, Y.; Yadav, A.K.; Ji, B.; Kang, P.; Wei, T. Ozone based inactivation and disinfection in the pandemic time and beyond: Taking forward what has been learned and best practice. Sci. Total Environ. 2023, 62, 160711. [Google Scholar] [CrossRef]
  63. Dubuis, M.E.; Dumont-Leblond, N.; Lalibert’e, C.; Veillette, M.; Turgeon, N.; Jean, J.; Duchaine, C. Ozone efficacy for the control of airborne viruses: Bacteriophage and norovirus models. PLoS ONE 2015, 20, e0231164. [Google Scholar] [CrossRef]
  64. Cristiano, L. Could ozone be an effective disinfection measure against the novel Coronavirus (SARS-CoV-2)? J. Prev. Med. Hyg. 2020, 61, E301–E303. [Google Scholar] [CrossRef]
  65. Kong, J.; Lu, Y.; Ren, Y.; Chen, Z.; Chen, M. The virus removal in U.V. irradiation ozonation and chlorination. Water Cycle 2021, 2, 23–31. [Google Scholar] [CrossRef]
  66. Fehr, A.R.; Perlman, S. Coronaviruses: An overview of their replication and pathogenesis. In Coronaviruses: Methods and Protocols; Maier, H.J., Bickerton, E., Britton, P., Eds.; Humana Press: Totowa, NJ, USA; Springer: New York, NY, USA, 2015; pp. 1–23. [Google Scholar]
  67. Zhou, P.; Yang, X.; Wang, X.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.R.; Zhu, Y.; Li, B.; Huang, C.L.; et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020, 579, 270–273. [Google Scholar] [CrossRef]
  68. Murray, B.K.; Ohmine, S.; Tomer, D.P.; Jensen, K.J.; Johnson, F.B.; Kirsi, J.J.; Robison, R.A.; O’Neill, K.L. Virion disruption by ozone-mediated reactive oxygen species. J. Virol. Methods 2008, 153, 74–77. [Google Scholar] [CrossRef]
  69. Hirneisen, K.A.; Markland, S.M.; Kniel, K.E. Ozone inactivation of norovirus surrogates on fresh produce. J. Food Prot. 2011, 74, 836–839. [Google Scholar] [CrossRef] [PubMed]
  70. Wolf, C.; Von Gunten, U.; Kohn, T. Kinetics of inactivation of waterborne enteric viruses by ozone. Environ. Sci. Technol. 2018, 52, 2170–2177. [Google Scholar] [CrossRef] [PubMed]
  71. Li, C.S.; Wang, Y.C. Surface germicidal effects of ozone for microorganisms. AIHAJ Am. Ind. Hyg. Assoc. 2003, 64, 533–537. [Google Scholar] [CrossRef]
  72. Young, S.; Torrey, J.; Bachmann, V.; Kohn, T. Relationship between inactivation and genome damage of human enteroviruses upon treatment by UV254 free chlorine and ozone. Food Environ. Virol. 2020, 12, 20–27. [Google Scholar] [CrossRef] [PubMed]
  73. Allison, K.; Hook, J.; Cardis, D.; Rice, R.G. Quantification of the bactericidal fungicidal and sporicidal efficacy of the J.L.A. Ltd ozone laundering system. Ozone Sci. Eng. 2009, 31, 369–378. [Google Scholar] [CrossRef]
  74. Wigginton, K.R.; Kohn, T. Virus disinfection mechanisms: The role of virus composition structure and function. Curr. Opin. Virol. 2012, 2, 84–89. [Google Scholar] [CrossRef] [PubMed]
  75. Uppal, T.; Khazaieli, A.; Snijders, A.M.; Verma, S.C. Inactivation of human coronavirus by FATHHOME’s dry sanitizer device: Rapid and eco-friendly ozone-based disinfection of SARS-CoV-2. Pathogens 2021, 10, 339. [Google Scholar] [CrossRef]
  76. Franke, G.; Knobling, B.; Brill, F.H.; Becker, B.; Klupp, E.M.; Belmar Campos, C.; Pfefferle, S.; Lütgehetmann, M.; Knobloch, J.K. An automated room disinfection system using ozone is highly active against surrogates for SARS-CoV-2. J. Hosp. Infect. 2021, 111, 108–113. [Google Scholar] [CrossRef] [PubMed]
  77. Yao, M.; Zhang, L.; Ma, J.; Zhou, L. On airborne transmission and control of SARS-CoV-2. Sci. Total Environ. 2020, 73, 139178. [Google Scholar] [CrossRef]
  78. De Forni, D.; Poddesu, B.; Cugia, G.; Gallizia, G.; La Licata, M.; Lisziewicz, J.; Chafouleas, J.; Lori, F. Low ozone concentration and negative ions for rapid SARS-CoV-2 inactivation. J. Biotechnol. Biomed. 2024, 7, 166. [Google Scholar] [CrossRef]
  79. Imoto, Y.; Matsui, H.; Ueda, C.; Nakajima, E.; Hanaki, H. Inactivation effects of hypochlorous acid, chlorine dioxide, and ozone on airborne SARS-CoV-2 and influenza A virus. Food Environ. Virol. 2025, 17, 9. [Google Scholar] [CrossRef] [PubMed]
  80. Torres-Mata, L.B.; García-Pérez, O.; Rodríguez-Esparragón, F.; Blanco, A.; Villar, J.; Ruiz-Apodaca, F.; Martín-Barrasa, J.L.; González-Martín, J.M.; Serrano-Aguilar, P.; Piñero, J.E.; et al. Ozone eliminates SARS-CoV-2 from difficult-to-clean office supplies and clinical equipment. Int. J. Environ. Res. Public Health 2022, 19, 8672. [Google Scholar] [CrossRef]
  81. Clavo, B.; Cordoba-Lanús, E.; Rodríguez-Esparragon, F.; Cazorla-Rivero, S.E.; García-Pérez, O.; Piñero, J.E.; Villar, J.; Blanco, A.; Torres-Ascensión, C.; Martín-Barrasa, J.L.; et al. Effects of ozone treatment on personal protective equipment contaminated with SARS-CoV-2. Antioxidants 2020, 9, 1222. [Google Scholar] [CrossRef]
  82. Wolfgruber, S.; Loibner, M.; Puff, M.; Melischnig, A.; Zatloukal, K. SARS-CoV2 neutralizing activity of ozone on porous and nonporous materials. New Biotechnol. 2022, 66, 36–45. [Google Scholar] [CrossRef]
  83. Choi, E.H.; Uhm, H.S.; Kaushik, N.K. Plasma bioscience and its application to medicine. AAPPS Bull. 2021, 31, 10. [Google Scholar] [CrossRef]
  84. Choudhury, B.; Lednicky, J.A.; Loeb, J.C.; Portugal, S.; Roy, S. Inactivation of SARS CoV-2 on porous and nonporous surfaces by compact portable plasma reactor. Front. Bioeng. Biotechnol. 2024, 29, 1325336. [Google Scholar] [CrossRef]
  85. Nakano, R.; Nakano, A.; Sasahara, T.; Suzuki, Y.; Nojima, Y.; Yano, H. Antiviral effects of copper and copper alloy and the underlying mechanisms in severe acute respiratory syndrome coronavirus 2. J. Hazard. Mater. Adv. 2025, 17, 100589. [Google Scholar] [CrossRef]
  86. Yano, H.; Nakano, R.; Suzuki, Y.; Nakano, A.; Kasahara, K.; Hosoi, H. Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment. J. Hosp. Infect. 2020, 106, 837–838. [Google Scholar] [CrossRef] [PubMed]
  87. Percivalle, E.; Clerici, M.; Cassaniti, I.; Vecchio Nepita, E.; Marchese, P.; Olivati, D.; Catelli, C.; Berri, A.; Baldanti, F.; Marone, P.; et al. SARS-CoV-2 viability on different surfaces after gaseous ozone treatment: A preliminary evaluation. J. Hosp. Infect. 2021, 110, 33–36. [Google Scholar] [CrossRef] [PubMed]
  88. Neves, E.S.; Ng, C.T.; Pek, H.B.; Goh, V.S.L.; Mohamed, R.; Osman, S.; Ng, Y.K.; Kadir, S.A.; Nazeem, M.; She, A.; et al. Field trial assessing the antimicrobial decontamination efficacy of gaseous ozone in a public bus setting. Sci. Total Environ. 2023, 876, 162704. [Google Scholar] [CrossRef] [PubMed]
  89. Frizziero, L.; Donnici, G.; Venditti, G.; Freddi, M. Design of an innovative sanitation system for bike-sharing service. Heliyon 2024, 10, e26595. [Google Scholar] [CrossRef]
  90. Westover, C.; Rahmatulloev, S.; Danko, D.; Afshin, E.E.; O’Hara, N.B.; Ounit, R.; Bezdan, D.; Mason, C.E. Ozone treatment for elimination of bacteria and SARS-CoV-2 for medical environments. Genes 2022, 14, 85. [Google Scholar] [CrossRef]
  91. Viana Martins, C.P.; Xavier, C.S.F.; Cobrado, L. Disinfection methods against SARS-CoV-2: A systematic review. J. Hosp. Infect. 2022, 119, 84–117. [Google Scholar] [CrossRef]
  92. Tizaoui, C.; Stanton, R.; Statkute, E.; Rubina, A.; Lester-Card, E.; Lewis, A.; Holliman, P.; Worsley, D. Ozone for SARS-CoV-2 inactivation on surfaces and in liquid cell culture media. J. Hazard. Mater. 2022, 428, 128251. [Google Scholar] [CrossRef]
  93. Hu, X.; Chen, Z.; Su, Z.; Deng, F.; Chen, X.; Yang, Q.; Li, P.; Chen, Q.; Ma, J.; Guan, W.; et al. Ozone water is an effective disinfectant for SARS-CoV-2. Virol. Sin. 2021, 36, 1066–1068. [Google Scholar] [CrossRef]
  94. Corzo-Leon, D.E.; Abbood, H.M.; Colamarinom, R.A.; Steiner, M.F.C.; Munro, C.; Gould, I.M.; Hijazi, K. Methods for SARS-CoV-2 hospital disinfection, in vitro observations. Infect. Prev. Pract. 2024, 6, 100339. [Google Scholar] [CrossRef] [PubMed]
  95. Takeda, Y.; Jamsransuren, D.; Makita, Y.; Kaneko, A.; Matsuda, S.; Ogawa, H.; Oh, H. Inactivation activities of ozonated water, slightly acidic electrolyzed water and ethanol against SARS-CoV-2. Molecules 2021, 26, 5465. [Google Scholar] [CrossRef]
  96. Yasugi, M.; Gunji, K.; Inagaki, K.; Kuroda, M.; Ii, C. Disinfection effect of ozonated water on SARS-CoV-2 in the presence of salivary proteins. J. Hosp. Infect. 2025, 155, 209–215. [Google Scholar] [CrossRef] [PubMed]
  97. Volkoff, S.J.; Carlson, T.J.; Leik, K.; Smith, J.J. Demonstrated SARS-CoV-2 surface disinfection using ozone. Ozone Sci. Eng. 2021, 43, 296–305. [Google Scholar] [CrossRef]
  98. Murata, T.; Komoto, S.; Iwahori, S.; Sasaki, J.; Nishitsuji, H.; Hasebe, T.; Hoshinaga, K.; Yuzawa, Y. Reduction of severe acute respiratory syndrome Coronavirus-2 infectivity by admissible concentration of ozone gas and water. Microbiol. Immunol. 2021, 65, 10–16. [Google Scholar] [CrossRef]
  99. Nishiki, Y.; Imazu, T.; Nakamuro, K.; Naitou, H.; Aoki, K.J. Inactivation mechanism of SARS-CoV-2 by ozone in aqueous and gas phases. J. Microorg. Control 2023, 28, 43–48. [Google Scholar] [CrossRef] [PubMed]
  100. Sallustio, F.; Cardinale, G.; Voccola, S.; Picerno, A.; Porcaro, P.; Gesualdo, L. Ozone eliminates novel coronavirus SARS-CoV-2 in mucosal samples. New Microbes New Infect. 2021, 43, 100927. [Google Scholar] [CrossRef] [PubMed]
  101. Nicolo, M.S.; Rizzo, M.G.; Palermo, N.; Gugliandolo, C.; Cuzzocrea, S.; Guglielmino, S.P.P. Evaluation of betacoronavirus OC43 and SARS-CoV-2 elimination by zefero air sanitizer device in a novel laboratory recirculation system. Pathogens 2022, 11, 221. [Google Scholar] [CrossRef] [PubMed]
  102. Diella, G.; Caggiano, G.; Apollonio, F.; Triggiano, F.; Stefanizzi, P.; Fasano, F.; Pace, L.; Marcotrigiano, V.; Sorrenti, D.P.; Sorrenti, G.T.; et al. SARS-CoV-2 RNA viability on high-touch surfaces and evaluation of a continuous-flow ozonation treatment. Ann. Ig. 2023, 35, 112–120. [Google Scholar] [CrossRef] [PubMed]
  103. Córdoba-Lanús, E.; García-Pérez, O.; Rodríguez-Esparragón, F.; Bethencourt-Estrella, C.J.; Torres-Mata, L.B.; Blanco, A.; Villar, J.; Sanz, O.; Díaz, J.J.; Martín-Barrasa, J.L.; et al. Ozone treatment effectively eliminates SARS-CoV-2 from infected face masks. PLoS ONE 2022, 17, e0271826. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Potent mechanism of ozone’s virucidal action on SARS-CoV-2 virus via direct and indirect oxidation.
Figure 1. Potent mechanism of ozone’s virucidal action on SARS-CoV-2 virus via direct and indirect oxidation.
Ijms 27 03632 g001
Table 1. Factors influencing microbial inactivation efficiency during gaseous and aqueous ozonization of different materials.
Table 1. Factors influencing microbial inactivation efficiency during gaseous and aqueous ozonization of different materials.
Material/SubstrateAmbient ConditionsOperational
TemperatureMaterial shape and porosityOzone concentration
pHContact angleOzonation duration
ConductivityContamination methodOzone generation method
Relative humidityLevel of microbial contaminationPenetrability
PressureSurface chemical compositionRadical generation (OH)
Dissolved concentration
organic matter
Concentration homogenization
Table 2. Ozone virucidal activity against SARS-CoV-2 on different surfaces and other liquid media.
Table 2. Ozone virucidal activity against SARS-CoV-2 on different surfaces and other liquid media.
Ozonation PhaseOzone-Based DeviceOzone
Concentration
Exposure
Time
Virus TypeMaterial/SubstrateSummary of
Findings
Ref.
AqueousIndustrial ozone generator (Grenof, Brisbane, Australia).0.375 ppm, 0.75 ppm, 1 ppm5 minSARS-CoV-2, QLD02 (GISAID accession EPI_ISL_407,896) and QLD935 (GISAID accession EPI_ISL_436,097)Cell line and virus isolates0.75 ppm aqueous ozone is highly effective in inactivating the virus after 5 min of incubation, with 0.375 ppm achieving 82–91.5% inactivation.[27]
AqueousDOCOL®0.2–0.8 ppm1 minSARS-Cov-2 in Vero CCL81 lineageVirus solutionA reduction in virus infectivity was observed after a 0.6 ppm ozone treatment for 1 min, corresponding to a 2 log10 reduction.[38]
AqueousND4.5, 9, 18, 36 ppm1, 5, 10 minSARS-CoV-2 in Vero E6 cell lineViral solution36 ppm aqueous ozonation fully inactivated the virus stock in <1 min.[92]
AqueousElectrolytic ozone water-generating device (Handlex, ONR-1, Nikkiso/Nikkamicron Co., Saitama/Tokyo, Japan)4, 7, 10 ppm1, 5–20 sSARS-CoV-2/Hu/D.P./Kng/19-027, LC528233Viral stock solutionVirus titer reduction rates after 5 s treatment with ozone concentrations of 1, 4, 7, and 10 ppm were 81.4%, 93.2%, 96.6%, and 96.6%, respectively.[39]
AqueousOzonated water7 ppm O3 solution was mixed with the virus (9:1 volume ratio)3 min and 10 minThree SARS-CoV-2 variants of concern (WHO label alpha, beta, gamma; Pango lineage B.1.1.7, B.1.351, P.1) in Vero E6 cells (ATCC-CRL1586)Viral solutionReduction in the viral activity of
<1 log
[94]
AqueousOzone water-generating device (Panasonic, Tokyo, Japan)1.5 mg/L5 minSARS-CoV-2 in Vero E6 cell lineSARS-CoV-2 in salivaOzonated water appeared to inactivate SARS-CoV-2 within 30 s. The amount of inactivated SARS-CoV-2 decreased as the protein concentration increased. Virus inactivation was stronger by 1.5 mg/L ozonated water than by 0.5 mg/L ozonated water.[96]
Gaseous and AqueousSTERISAFE Pro version 1.0, STERISAFE ApS, Ole Maaløe’s vej 5, DK-2200 Copenhagen, Denmark0.5–20 g·min/m33, 5, 20 minBacteriophage F6 and BCoVStainless steel, copper, plastic, glass, coupons of ambulance seats, and flooring15 g/min/m3 ozone and 81% R.H., a reduction of up to 2 logs was observed on stainless steel and glass. A constant inactivation rate for the liquid was 7 × 105 M−1 s−1.[92]
Gaseous/AqueousSanozone™ O3 generator (Sanozone, Regina, SK, Canada)4.5 and 9 ppm10–90 minRecombinant mammalian cell product, bacteriophage MS2, and SARS-CoV-2Polyester, stainless steel, plastic, and paper. Water treatment was also performedAfter 4.5 and 9 ppm ozone exposure for 60–90 min, no virus RNA was recovered from plastic surfaces[97]
Gaseous/AqueousOzone gas and L CLEAN Minnie (Tamura TECO Co., Ltd., Higashiosaka City, Japan)0.05–2 ppm10 s–20 hSARS-Cov-2 in VeroE6/TMPRSS2 cellsStainless steel for gaseous exposure and viral solutions.0.05 and 0.1 ppm ozone gas treatment decreased virus infectivity by ~95% in 10 and 20 h, depending on R.H.
1 and 2 mg/L ozonated water treatment reduced virus infectivity by about 2 and 3 logs in 10 s
[98]
Gaseous and AqueousOzone-gas generator (MXAP-AE270, Maxell Ltd., Tokyo, Japan) and Ozonated water generator (MXZW-WM100J, Maxell Ltd., ejector type0.05 ppmv and 0.2 mg/L12–24 h and
30 s and 60 s
SARS-CoV-2; 2019-nCoV JPN/TY/WK-521 strainViral solutionInactivation in the gas phase requires 1014–1015 ozone molecules per virus virion, while the inactivation in the aqueous phase requires 5 × 1010 to 5 × 1011 ozone molecules[99]
GaseousICON3 device0–5.5 ppm0–45 minSARS-CoV-2 in Vero E6 cells (kidney epithelial cells from African green monkey, ATCC CRL-1586)Virus suspensions in well plates3.18 ppm of ozone inactivated > 99% of the virus within 20 min.[78]
GaseousMedical ozone generator (Ozonobaric P®, Sedecal, Madrid, Spain)19, 33, 70, and 90 ppm
2000, 4000, 10,000 ppm
30, 60, 90, and 120 min
5, 10 min
SARS-CoV-2 strain 2019-nCoV/USA-WA1/2020Office supplies (personal computer monitors, keyboards, and mice) and clinical equipment (continuous positive airway pressure tubes and PPE)4000 ppm ozone eliminated viral RNA within 10 min[80]
GaseousMedical ozone generators (Ozonobaric P®, Sedecal, Madrid, Spain)4–12 ppm
500–40,000 ppm
0.5, 1, 5, 10 minSARS-CoV-2 strain 2019-nCoV/USA-WA1/2020PPE gowns and facemasksNo viral amplification was detected after ozone exposure (2000 ppm or higher). At lower concentrations (4–12 ppm), inactivation depended on R.H.[81]
GaseousPlasma generator (CeraPlas™ element, Relyon Plasma GmbH, Regensburg, Germany)800 ppm10–60 minSARS-CoV-2 virus isolate (Human 2019-nCoV Isolate ex China Strain: BavPat1/2020)Cotton facemasks, FFP3 facemasks, glass slides800 ppm ozone exposure within 10–60 min demonstrated
>6 log reduction
[82]
GaseousDBD plasma120 ppm with power 13 W10–300 sHCoV-229EFace mask-94 (KF94)Reduce the viral RNA load to 4 log orders with an ozone concentration of 120 ppm, exposed for 10 s[83]
GaseousDevice generating ozone gas (TM-04OZ; Tamura TECO Ltd., Higashiosaka City, Osaka, Japan)1, 6 ppm55, 60 minSARS-CoV-2 (JPN/TY/WK-521) strain in VeroE6/TMPRSS2 cells (JCRB1819)Stainless steelA 6 ppm ozone gas exposure for 55 min yielded a 3 log10 reduction (PFU/mL) in viral load.[38]
GaseousND0.5, 1, 2 ppm40, 60 minSARS-CoV-2Painted aluminum, non-painted aluminum, FFP2 masks, glass, plastic, surgical gown, Plexiglas, stainless steelIn 60 min, ~85–90% viability reduction on all surfaces at all concentrations[88]
GaseousSani Suport Supreme20 ppm30 min, 1 h, 2 h, 3 h, 4 hTwist synthetic SARS-CoV-2 RNA.Blankets, remotes, catheters, and syringesAt 240 min, ~99% capsid RNA was degraded[28]
GaseousOzonext Defender 10 (Cea S.p.A., Lecco, Italy)0.2 and 4 ppm30–120 minhCoV-19/Italy/UniSR1/2020 (GISAID accession ID: EPI_ISL_413489) in Vero E6 cellsWood, gauze, fleece, glass, and plastic4 ppm ozone exposure within 30 min yielded a 90% reduction in viral titers for all materials[91]
GaseousBio3gen apparatus (Finlinea s.p.a., Gazzaniga, Bergamo, Italy)400 mg/h
3.6 L/min
4 minSARS-CoV-2SwabsThe real-time detection kit tested negative[100]
GaseousAir sanitizer “Zefero” (Cf7 S.r.l., S. Giovanni La Punta, Catania, Italy)5 g/h in a chamber of 0.033 m315, 30 minBetacoronavirus OC43 and SARS-CoV-2Aerosol samplingAfter 30 min of ozone exposure, the virus was fully eliminated.[101]
GaseousOzonization system (model GX, Ozotek®, Taranto, Italy)2.64 g/h2 h 30 minSARS-CoV-2 isolation in Vero E6 cell line (African green monkey kidney cells)Supermarket (scales, refrigerator handles, shopping trolley handles, cash register keyboards, and P.O.S. keyboards)There is no statistically significant difference between supermarkets with and without an ozonation system.[102]
GaseousOzone generator (Ozonobaric P1, Sedecal, Madrid, Spain)2000, 4000, and 10,000 ppm1, 2, 5, and 10 minSARS-CoV-2 in VERO E6 cells (ATCC CRL-1586)Face masks, viral solutionThe best-evaluated option in this study was 4000 ppm (8 g/m3) for 2 min.[103]
GaseousOzone gas generator (Mitsubishi Heavy Industries, Ltd., Tokyo, Japan).0.1, 0.3, and 1.0 ppm0 min, 100 s, 5 min, and 10 minSARS-CoV-2 strain 2019-nCoV/Japan/TY/WK-521/2020 in VeroE6/TEMPRESS2 cells (JCRB1819)A mixed sample of SARS-CoV-2 and influenza A virus in diluted salivaThe concentrations of ozone in the air reached a 2 log reduction in SARS-CoV-2 infectivity titer within 10 min at 1.0 ppm.[79]
GaseousCompact Portable Plasma Reactor (CPPR)1 ppm5–15 minSARS-CoV-2 strain UF-1 and HCoV-OC43 strain JAL-1 in Vero E6 cellsSARS-CoV-2 and HCoV-OC43 on representative porous (KN95 mask material) and nonporous materials (aluminum and polycarbonate)Minimum CPPR exposure times of 5–15 min resulted in a 4–5 log reduction in SARS-CoV-2 and its surrogate on representative material samples.[84]
GaseousVirestorm V5 ozone generatorBetween 13 and 18 ppm55, 85, and 210 minMurine hepatitis virus (MHV-a related betacoronavirus surrogate) and Staphylococcus aureusCarriers-Stainless steel disks3.65 log reduction in murine hepatitis virus and a 4.73 log decrease in S. aureus[89]
GlycerolOzonizer (Mediplus Co., Tokyo, Japan)20, 200, 500, and 1000 ppm20 s, 1 h,
and 24 h
SARS-CoV-2 (JPN/TY/WK-521 strain) in VeroE6/TMPRSS2 cells (cell number: JCRB1819)Viral solution500 ppm ozonated glycerol at 20% of F.B.S. concentration for 1 h was ≥99.91% of virus inactivation [95]
ND: Not described.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rangel, K.; Villas-Bôas, M.H.S.; De-Simone, S.G. Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review. Int. J. Mol. Sci. 2026, 27, 3632. https://doi.org/10.3390/ijms27083632

AMA Style

Rangel K, Villas-Bôas MHS, De-Simone SG. Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review. International Journal of Molecular Sciences. 2026; 27(8):3632. https://doi.org/10.3390/ijms27083632

Chicago/Turabian Style

Rangel, Karyne, Maria Helena Simões Villas-Bôas, and Salvatore Giovanni De-Simone. 2026. "Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review" International Journal of Molecular Sciences 27, no. 8: 3632. https://doi.org/10.3390/ijms27083632

APA Style

Rangel, K., Villas-Bôas, M. H. S., & De-Simone, S. G. (2026). Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review. International Journal of Molecular Sciences, 27(8), 3632. https://doi.org/10.3390/ijms27083632

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop